U01CA260851
Cooperative Agreement
Overview
Grant Description
Phase separation-induced nuclear organization in ALT cancer.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Place of Performance
Pittsburgh,
Pennsylvania
152133815
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 389% from $530,948 to $2,596,162.
Carnegie Mellon University was awarded
Phase separation-induced nuclear organization in ALT Cancer
Cooperative Agreement U01CA260851
worth $2,596,162
from the National Institute of Allergy and Infectious Diseases in September 2020 with work to be completed primarily in Pittsburgh Pennsylvania United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.310 Trans-NIH Research Support.
The Cooperative Agreement was awarded through grant opportunity New Investigator Projects on 4DN Organization and Function in Human Health and Disease (U01 Clinical Trial Not Allowed).
Status
(Complete)
Last Modified 9/20/24
Period of Performance
9/10/20
Start Date
8/31/25
End Date
Funding Split
$2.6M
Federal Obligation
$0.0
Non-Federal Obligation
$2.6M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U01CA260851
Transaction History
Modifications to U01CA260851
Additional Detail
Award ID FAIN
U01CA260851
SAI Number
U01CA260851-650412812
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
U3NKNFLNQ613
Awardee CAGE
97668
Performance District
PA-12
Senators
Robert Casey
John Fetterman
John Fetterman
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Office of the Director, National Institutes of Health, Health and Human Services (075-0846) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,551,253 | 100% |
Modified: 9/20/24